Anne Wojcicki’s nonprofit gets court approval to buy 23andMe for $305 million
By WYATTE GRANTHAM-PHILIPS
NEW YORK (AP) — Anne Wojcicki’s bid to buy 23andMe, the genetic testing company she cofounded nearly 20 years ago, has received the court greenlight.
Related Articles
-
Weather clears as SpaceX launches European satellite -
Consumer Financial Protection Bureau dismisses $95M overdraft case vs. Navy Federal Credit Union -
Fireworks will light up this Fourth of July. Next year could be different if tariff talks fizzle -
AI ghosts: Researchers explore planning for death with new technology -
Fed vs. Trump on tariffs impact will soon be put to test
That means Wojcicki’s nonprofit TTAM Research Institute will purchase “substantially all” of San Francisco-based 23andMe’s assets for $305 million. The transaction — which arrives more than three months after 23andMe filed for Chapter 11 bankruptcy — is set to officially close in the coming weeks.
“I am thrilled that TTAM will be able to build on the mission of 23andMe to help people access, understand and benefit from the human genome,” Wojcicki said in a statement Monday — later adding that, “the future of health care belongs to all of us.”
